# Labetalol

## Trandate inj 25mg/5mL

| TAH Drug Code      | [ITRAD](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ITRAD)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Hypertension.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Dosing             | IV bolus: Given 50 mg over 1 minute and may repeat every 5 minutes until desired blood pressure is achieved or up to a total maximum of 200 mg. IV infusion: Diluted with saline or 5% Dextrose solution to 1 mg/mL, administered 2 mg/minute initially. Gestational hypertension: Initial, 20mg/hour as an IV infusion, then double the dose in every 30 minutes until desired blood pressure is achieved or up to 160mg/hours. May give higher dosage when necessary. Blood pressure management in acute myocardial infarction: Initially give 15 mg/hour via infusion then increase gradually to maximum 120 mg/hour adjusted by blood pressure. Hypertension due to other causes: Initially give 2 mg/minute via infusion then adjust infusion rate to blood pressure response. The effective dose usually around 50-200 mg. Higher dosage may be required in particular patients, especially with pheochromocytoma. The infusion rate can be adjusted by the doctor according to the reaction. Blood pressure management in operative procedure: Initially IV 10-20 mg, add supplemental dose 5-10 mg every 5 minutes until target blood pressure is reached. (use with halothane) Patients with contraindications for halothane usually need the higher initial dose (25-30 mg). |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Contraindications  | 2nd or 3rd degree heart block, cardiogenic shock, severe & prolonged hypotension or severe bradycardia. Hypertensive episodes after acute MI when peripheral vasoconstriction suggests low cardiac output.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Adverse Effects    | Pronounced postural hypotension, nasal congestion. Rarely hypersensitivity, rash, pruritus, angioedema & dyspnea; raised liver function tests, jaundice, hepatitis & hepatitis necrosis; bradycardia, heart block. Cardiovascular: Orthostatic hypotension (1%, oral ; 58%, IV ) Dermatologic: Has tingling sensation (7% .) Gastrointestinal: Nausea (14% ) Neurologic: Dizziness (9% to 20% ) Respiratory: Nasal congestion (3% ) Other: Fatigue (11% )                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Pregnancy          | Human Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |

## Labtal 200mg

| TAH Drug Code      | [OLAB](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OLAB)                                                                                                                                                                                                                                                                                                                                                                                                                       |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Mild to severe hypertension, hypertension in pregnancy, angina pectoris with coexisting hypertension.                                                                                                                                                                                                                                                                                                                                                                                      |
| Dosing             | Hypertension: Initially 100 mg BID. May increase in increments of 100 mg twice daily intermittently in every 2-14 days. Maximum: 800 mg/day in 2 divided doses. Patients with severe hypertension may require 2400 mg/day, in 3-4 divided doses. Gestational hypertension: Initially 100 mg BID. May increase in increments of 100 mg twice daily intermittently in 1-week interval. Total daily dose may be divided to 3 doses for patient with severe hypertension. Maximum: 2400mg/day. |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Contraindications  | Second or 3rd degree heart block, cardiogenic shock, severe and prolonged hypotension or severe bradycardia. Hypertensive episodes after acute MI when peripheral vasoconstriction suggests low cardiac output.                                                                                                                                                                                                                                                                            |
| Adverse Effects    | Pronounced postural hypotension, nasal congestion. Rarely hypersensitivity, rash, pruritus, angioedema and dyspnea; raised liver function tests, jaundice, hepatitis and hepatitis necrosis; bradycardia, heart block. Cardiovascular: Orthostatic hypotension (1%, oral ; 58%, IV ) Dermatologic: Has tingling sensation (7% .) Gastrointestinal: Nausea (14% ) Neurologic: Dizziness (9% to 20% ) Respiratory: Nasal congestion (3% ) Other: Fatigue (11% )                              |
| Pregnancy          | Human Data Suggest Risk in 2nd and 3rd Trimesters                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                              |

